biotechnology – Benefits Canada.com https://www.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Fri, 03 May 2024 21:03:19 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 2023 Investment Innovation Conference: How emerging medical technology is disrupting traditional health-care investments https://www.benefitscanada.com/canadian-investment-review/post-event-coverage/2023-investment-innovation-conference-how-emerging-medical-technology-is-disrupting-traditional-health-care-investments/ Thu, 18 Jan 2024 13:00:18 +0000 https://www.benefitscanada.com/?p=149007 Innovations in medical technology in the next 10 years could unlock a new dawn of health investments that will make the last decade look slow in comparison, said Daniel Kraft, a Stanford University and Harvard University trained physician-scientist, inventor, entrepreneur and investor, during the keynote session at the Canadian Investment Review’s 2023 Investment Innovation Conference […]

The post 2023 Investment Innovation Conference: How emerging medical technology is disrupting traditional health-care investments appeared first on Benefits Canada.com.

]]> OMERS’ real estate arm developing French laboratories, PSP-backed firm investing in Tokyo data centre https://www.benefitscanada.com/canadian-investment-review/alts/omers-real-estate-arm-developing-french-laboratories-psp-backed-firm-investing-in-tokyo-data-centre/ Tue, 24 May 2022 17:00:03 +0000 https://www.benefitscanada.com/?p=121833 The real estate arm of the Ontario Municipal Employees’ Retirement System is entering a long-term strategic partnership to develop commercial laboratories in France. In the agreement it reached with French urban investor and developer NoVaxia Inc., the Oxford Property Group will co-manage approximately €1 billion ($1.4 billion) in assets which will be invested in life sciences […]

The post OMERS’ real estate arm developing French laboratories, PSP-backed firm investing in Tokyo data centre appeared first on Benefits Canada.com.

]]> Is there a place for psychedelics in institutional portfolios? https://www.benefitscanada.com/news/cir-news-news/is-there-a-place-for-psychedelics-in-institutional-portfolios/ Thu, 20 May 2021 13:00:02 +0000 https://www.benefitscanada.com/?p=100769 With the global psychedelic drugs market projected to grow at a compound annual growth rate of 12.36 per cent between 2021 and 2027 to a value of US$10.75 billion in 2027 and the world’s first psychedelic exchange-traded fund launched in Canada at the start of the year, should institutional investors be taking notice? Read: Is it […]

The post Is there a place for psychedelics in institutional portfolios? appeared first on Benefits Canada.com.

]]>